TRVI logo

Trevi Therapeutics (TRVI) Working Capital

Annual Working Capital

$81.72 M
-$27.49 M-25.17%

December 31, 2023


Summary


Performance

TRVI Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTRVIbalance sheetmetrics:

Quarterly Working Capital

$58.21 M
-$7.16 M-10.96%

September 30, 2024


Summary


Performance

TRVI Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTRVIbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

TRVI Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.2%-28.8%
3 y3 years+100.7%+179.9%
5 y5 years+1229.3%-3.8%

TRVI Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-25.2%+223.9%-48.3%+243.0%
5 y5-year-25.2%+223.9%-48.3%+243.0%
alltimeall time-25.2%+1229.3%-48.3%+846.9%

Trevi Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$58.21 M(-11.0%)
Jun 2024
-
$65.38 M(-8.6%)
Mar 2024
-
$71.49 M(-12.5%)
Dec 2023
$81.72 M(-25.2%)
$81.72 M(-7.9%)
Sep 2023
-
$88.78 M(-6.1%)
Jun 2023
-
$94.50 M(-6.4%)
Mar 2023
-
$101.00 M(-7.5%)
Dec 2022
$109.22 M(+332.8%)
$109.22 M(-3.1%)
Sep 2022
-
$112.68 M(+74.8%)
Jun 2022
-
$64.45 M(+279.8%)
Mar 2022
-
$16.97 M(-32.7%)
Dec 2021
$25.23 M
$25.23 M(+21.3%)
DateAnnualQuarterly
Sep 2021
-
$20.79 M(-28.5%)
Jun 2021
-
$29.07 M(-21.1%)
Mar 2021
-
$36.82 M(-9.6%)
Dec 2020
$40.71 M(-25.1%)
$40.71 M(-17.1%)
Sep 2020
-
$49.11 M(+24.1%)
Jun 2020
-
$39.57 M(-15.1%)
Mar 2020
-
$46.61 M(-14.2%)
Dec 2019
$54.35 M(+784.1%)
$54.35 M(-10.2%)
Sep 2019
-
$60.51 M(-10.4%)
Jun 2019
-
$67.50 M(+508.2%)
Mar 2019
-
$11.10 M(+80.5%)
Dec 2018
$6.15 M(-59.1%)
$6.15 M
Dec 2017
$15.04 M
-

FAQ

  • What is Trevi Therapeutics annual working capital?
  • What is the all time high annual working capital for Trevi Therapeutics?
  • What is Trevi Therapeutics annual working capital year-on-year change?
  • What is Trevi Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Trevi Therapeutics?
  • What is Trevi Therapeutics quarterly working capital year-on-year change?

What is Trevi Therapeutics annual working capital?

The current annual working capital of TRVI is $81.72 M

What is the all time high annual working capital for Trevi Therapeutics?

Trevi Therapeutics all-time high annual working capital is $109.22 M

What is Trevi Therapeutics annual working capital year-on-year change?

Over the past year, TRVI annual working capital has changed by -$27.49 M (-25.17%)

What is Trevi Therapeutics quarterly working capital?

The current quarterly working capital of TRVI is $58.21 M

What is the all time high quarterly working capital for Trevi Therapeutics?

Trevi Therapeutics all-time high quarterly working capital is $112.68 M

What is Trevi Therapeutics quarterly working capital year-on-year change?

Over the past year, TRVI quarterly working capital has changed by -$23.51 M (-28.77%)